Hinge Health Stock for Accredited Investors

Healthcare
CEO Daniel Perez Founded 2014 HQ San Francisco, US

Hinge Health is a digital health company that provides virtual musculoskeletal care, including exercise therapy, wearable devices, and access to clinicians. It uses technology and AI-powered motion tracking to improve outcomes and help employers and health plans reduce care costs.

Access to pre-IPO shares is available to accredited investors through UpMarket.

Latest Price
$3.0B
IPO, May 2025, Perplexity
UpMarket Estimate
$3.1B
Based on UpMarket valuation model
Previous Price
$6.2B
Series E Oct 2021

How to Invest in Hinge Health Through UpMarket

Hinge Health shares are not on public exchanges. UpMarket provides accredited investors access through secondary market transactions.

Step 01

Verify accredited investor status

Confirm eligibility under SEC Rule 501 of Regulation D. Income or net worth threshold applies.

Step 02

Create an UpMarket account

Complete KYC/AML onboarding. Typically 1–2 business days. Licensed rep assigned on signup.

Step 03

Review available Hinge Health offerings

Full offering memoranda and risk disclosures provided before any commitment is required.

Step 04

Complete subscription documents

Review and sign subscription agreement. All documents handled digitally through the platform.

Step 05

Fund your investment

Wire transfer or ACH. $50K minimum. Funds held in custodial account until close.

Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.

${{aum_amount_brokered_en}}B+
UpMarket has brokered over ${{aum_amount_brokered_en}} billion in alternative investments*
*Includes principal invested and appreciation of investments originated via the UpMarket platform based on historical trade volume and valuation estimates through {{aum_as_of_date_en}}. Of the total, approximately ${{aum_amount_managed_en}} million is managed by UpMarket Management, with the remaining originated investments managed by affiliates. Past performance is not predictive of future results.

Valuation Growth Over Time

Post-money valuation by round
Previous rounds Most recent
DateRoundPPS (split-adj.)Valuation
May 2025 IPO $3.0B
Oct 2021 Series E $6.2B
Sep 2020 Series D $3.6B
Mar 2019 Series C $1.3B
Jun 2018 Series B $500M

Hinge Health Revenue and Growth

Annual revenue

Why Investors Are Watching Hinge Health

Growth Signal

Hinge Health guides 2026 revenue to about $798M-$804M

The company expects 2026 revenue of $798 million to $804 million, implying about 36% year-over-year growth at the midpoint. In Q1 2025, revenue rose 47% year over year to $182.3 million, showing sustained top-line momentum.

Competitive Moat

Hinge Health serves 1.3K customers and 25M members

The company says it serves self-insured employers and has 1.3K customers reaching 25 million members, giving it scale in musculoskeletal care. Its platform combines exercise therapy, wearable tech, behavioral coaching, and 24/7 physical therapist access, which can deepen switching costs.

Market Opportunity

Digital health market could reach $1.6T by 2032

Contrary estimates the global digital health market at $217 billion in 2022 and projects growth to $1.6 trillion by 2032. Hinge Health targets employers and health plans seeking lower costs for joint and muscle care, placing it in a large expanding category.

Interested in Hinge Health stock? Fill out the form above or sign up directly. Subject to availability. Accredited investors only.

Request access →

Hinge Health Leadership Team

Daniel Perez
CEO
Jim Pursley
President
Nathan Swartley
Chief of Staff

UpMarket Investment Curation Process

  • Full diligence on every offering

    UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.

  • Strategy, fees & legal reviewed in full

    We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers — legal counsel, auditor, administrator, and custodian.

  • Disciplined managers only

    We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.

  • Built around your objectives

    Our goal is to empower you to build a portfolio that best meets your individual investment objectives.

Ready to access institutional-grade private market investments? Unlock private markets

Hinge Health Stock FAQ

No. As of March 2026, Hinge Health is a private company and does not trade on any public stock exchange. Accredited investors can access Hinge Health shares through UpMarket, a FINRA-registered broker-dealer that specializes in pre-IPO investments.

Hinge Health does not have a public stock price because it is privately held. The most recent known share price comes from its last funding round. Pre-IPO share prices on the secondary market may differ from the last round price depending on supply, demand, and market conditions.

Yes. Accredited investors can indicate interest in Hinge Health shares through UpMarket by filling out the form on this page or creating an account at upmarket.co. All pre-IPO offerings are subject to availability and require a $50,000 minimum investment. UpMarket is a FINRA-registered broker-dealer and has brokered alternative investments since 2019.

Pre-IPO investments carry significant risks. Hinge Health shares are illiquid, meaning there is no public market to sell them quickly. There is no guaranteed exit timeline or return. The investment is speculative in nature, and investors should be prepared for the possibility of total loss. Valuations of private companies can fluctuate substantially between funding rounds. Investors should consult their financial advisor and review all offering documents before investing.

In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.

There are two primary exit paths for pre-IPO holdings: selling your shares on the secondary market to another buyer, or holding until the company completes an IPO or is acquired. Both paths are subject to transfer restrictions, company approval (right of first refusal), and market conditions. The timing of any exit is unpredictable, and investors should plan for a multi-year holding period.

The minimum investment for most pre-IPO offerings on UpMarket is $50,000. This amount may vary depending on the specific offering and share availability. There are no fees to create an UpMarket account or browse available investments. Investors only pay transaction-related fees when they complete an investment.

UpMarket's valuation estimate of is derived from a proprietary model that incorporates multiple data sources: funding round data (Caplight), revenue estimates (Sacra), secondary market pricing, and public company comparables. The model applies a private company discount to the public comp multiple to account for illiquidity and information asymmetry. This estimate is not investment advice and may differ substantially from the price at which shares actually trade.

Hinge Health provides virtual musculoskeletal care through exercise therapy, wearable devices, and clinician support, generated $390M in 2024 revenue, and is guiding 2026 revenue to about $798M-$804M — accredited investors can access Hinge Health stock through UpMarket.

Invest in Hinge Health Request access